Literature DB >> 22882337

Churg-Strauss syndrome manifesting as cholestasis and diagnosed by liver biopsy.

Masaru Harada1, Shinji Oe, Michihiko Shibata, Masashi Taguchi, Toru Matsuhashi, Masaaki Hiura, Shintaro Abe, Riko Harada, Shohei Shimajiri.   

Abstract

A 56-year-old woman was referred to our hospital due to fever and cholestatic liver dysfunction. Her eosinophil count was normal and she had no abdominal pain or neurological manifestations. We performed a liver biopsy and found fibrinoid necrosis of the hepatic artery with granulomatous reaction and eosinophilic infiltration in the portal area in the liver. Later, sensory abnormalities of the arms and legs appeared and the eosinophil count increased. Serum immunoglobulin E and immunoglobulin G4 were elevated and rheumatoid factor was strongly positive. Endoscopic retrograde cholangiopancreatography revealed no abnormality of the bile duct and pancreatic duct. We made a diagnosis of Churg-Strauss syndrome and began corticosteroid treatment. Fever and liver function immediately improved. In the present patient, Churg-Strauss syndrome manifested first in the liver, before hypereosinophilia and neural manifestations. We believe that Churg-Strauss syndrome is an autoimmune liver disease, and it is important to recognize that the liver may be involved in Churg-Strauss syndrome.
© 2012 The Japan Society of Hepatology.

Entities:  

Year:  2012        PMID: 22882337     DOI: 10.1111/j.1872-034X.2012.00993.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  2 in total

1.  Eosinophil-rich granuloma of the liver.

Authors:  Ming-Hsun Li; Yung-Hsiang Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-08-01

Review 2.  Imaging of intestinal vasculitis focusing on MR and CT enterography: a two-way street between radiologic findings and clinical data.

Authors:  Mehrnam Amouei; Sara Momtazmanesh; Hoda Kavosi; Amir H Davarpanah; Ali Shirkhoda; Amir Reza Radmard
Journal:  Insights Imaging       Date:  2022-09-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.